MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 338 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $15,576,000 | +36.5% | 258,308 | +4.1% | 0.05% | +33.3% |
| Q1 2016 | $11,411,000 | +0.6% | 248,177 | +4.9% | 0.04% | -2.7% |
| Q4 2015 | $11,347,000 | +12.9% | 236,494 | -0.0% | 0.04% | +5.7% |
| Q3 2015 | $10,051,000 | -19.1% | 236,495 | +117.5% | 0.04% | -14.6% |
| Q2 2015 | $12,419,000 | -8.6% | 108,744 | +3.3% | 0.04% | -10.9% |
| Q1 2015 | $13,592,000 | +37.1% | 105,307 | +5.8% | 0.05% | +31.4% |
| Q4 2014 | $9,911,000 | – | 99,496 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |